S
Stephen K. Frankel
Researcher at University of Colorado Denver
Publications - 51
Citations - 3092
Stephen K. Frankel is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Interstitial lung disease & Idiopathic pulmonary fibrosis. The author has an hindex of 26, co-authored 51 publications receiving 2553 citations. Previous affiliations of Stephen K. Frankel include University of Colorado Hospital & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer,Kevin K. Brown,Roland M. du Bois,Stephen K. Frankel,Gregory P. Cosgrove,Evans R. Fernandez-Perez,Tristan J. Huie,Mahalakshmi Krishnamoorthy,Richard T. Meehan,Amy L. Olson,Joshua J. Solomon,Jeffrey J. Swigris +11 more
TL;DR: Small series suggest mycophenolate mofetil (MMF) is well tolerated and may be an effective therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD) and is associated with either stable or improved pulmonary physiology over a median 2.5 years of followup.
Journal ArticleDOI
Idiopathic Pleuroparenchymal Fibroelastosis: Description of a Novel Clinicopathologic Entity
TL;DR: In this paper, the authors characterized the clinical, radiographic, physiologic, and pathologic findings of a unique idiopathic pleuroparenchymal fibroelastosis.
Journal ArticleDOI
A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure
Marc Moss,Amy Nordon-Craft,Daniel C Malone,David Van Pelt,Stephen K. Frankel,Mary Laird Warner,Wendy Kriekels,Monica McNulty,Diane L. Fairclough,Margaret Schenkman +9 more
TL;DR: An intensive PT program did not improve long-term physical functional performance compared with a standard-of-care program and there were no differences in the total CS-PFP-10 scores at all three time points.
Journal ArticleDOI
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Joshua J. Solomon,Jonathan H. Chung,Gregory P. Cosgrove,M. Kristen Demoruelle,Evans R. Fernandez-Perez,Aryeh Fischer,Stephen K. Frankel,Stephen B. Hobbs,Tristan J. Huie,Jill Ketzer,Amar Mannina,Amy L. Olson,Gloria Russell,Yutaka Tsuchiya,Zulma X. Yunt,Pearlanne T. Zelarney,Kevin K. Brown,Jeffrey J. Swigris +17 more
TL;DR: Data from this study suggest that in rheumatoid-arthritis associated interstitial lung disease, disease progression and survival differ between subgroups defined by HRCT pattern; however, when controlling for potentially influential variables, pulmonary physiology, but notHRCT pattern, independently predicts mortality.
Journal ArticleDOI
Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
Jeffrey J. Swigris,Amy L. Olson,Aryeh Fischer,David A. Lynch,Gregory P. Cosgrove,Stephen K. Frankel,Richard T. Meehan,Kevin K. Brown +7 more
TL;DR: MMF appears to be safe and well tolerated in patients with CTD-ILD, and larger-scale studies are needed to further evaluate the efficacy of MMF in this patient population.